Annual general meeting (amended notice)
Notice is hereby given that the 165th annual general meeting of the members of the Royal Pharmaceutical Society will take place at the Westminster Suite, Queen Elizabeth II Conference Centre, Broad Sanctuary, London SW1P 3EE, on Wednesday 24 May 2006, at 7.30pm.
The following business will be conducted:
1. Presentation of the annual review of the Council for 2005
2. Presentation of the financial statements for 2005
3. Report of revisions to the Code of Ethics issued since the 2005 annual general
meeting
4. Adoption of rules of procedure for debate of motions (Byelaws, Section VI,
Paragraph 3): “A member may raise any matter or move any motion at any
annual general meeting of which he has given the Secretary notice in writing
no later than the 20th day of April in the year of which the said meeting is
to be held. The Rules of Procedure for debating such motions shall be proposed
by the Council and presented for adoption at each annual general meeting at
which such a motion is to be moved.” The proposed rules will be circulated
at the meeting.
5. Consideration of any matters raised or motions moved by members of which
notice has been given in writing no later than 20 April 2006.
(i) The following motion will be moved by William A. Gould: “This meeting
calls upon the Council members of the Royal Pharmaceutical Society to adopt
and implement standards of behaviour
which are not only ethically
high but are seen to be high.”
Ann Lewis
Secretary and Registrar
The following programme of events takes place on Wednesday 24 May before
the AGM:
5.30pm, tea and sandwiches available for those attending the
AGM
6.15pm, presentation of fellowship certificates for 2005, followed
by presentation of the Charter gold medal and Charter silver medal for
2006
7pm, discussion forum (an informal opportunity for members to raise
issues they wish to discuss). |
The
Pharmaceutical Journal